.rll-youtube-player .play{--wpr-bg-7ab8ebad-be22-45de-b57b-c0c467fcad4b: url('https://www.stocksregister.com/wp-content/plugins/wp-rocket/assets/img/youtube.png');}.perfmatters-lazy-youtube .play{--wpr-bg-572eaa62-67aa-4030-8782-6dca29b6d065: url('https://www.stocksregister.com/wp-content/plugins/perfmatters/img/youtube.svg');}

Tag: Y-mAbs Therapeutics Inc.

Business

Y-Mabs Therapeutics Inc (YMAB) Touches $11.88: At This Price, The Risk Is Worth It

Y-Mabs Therapeutics Inc (NASDAQ:YMAB) concluded the trading at $11.88 on Wednesday, November 27, with a rise of 10.31% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $10.77 and 5Y monthly beta

Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.

Tag: Y-mAbs Therapeutics Inc.

Y-Mabs Therapeutics Inc (YMAB) Touches $11.88: At This Price, The Risk Is Worth It

Quick Links

Categories

All rights reserved ©2024, Powered by Smart TechOne